FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NeuroPace's Free Cash Flow for the
three
months ended in Dec. 2023 was $-3.37 Mil. NeuroPace's Revenue for the
three
months ended in Dec. 2023 was $18.01 Mil. Therefore, NeuroPace's FCF Margin % for the quarter that ended in Dec. 2023 was -18.73%.
The historical rank and industry rank for NeuroPace's FCF Margin % or its related term are showing as below:
NPCE'
s FCF Margin % Range Over the Past 10 Years
Min: -82.32 Med: -55.24 Max: -30.38
Current: -30.38
During the past 5 years, the highest FCF Margin % of NeuroPace was -30.38%. The lowest was -82.32%. And the median was -55.24%.
NPCE's FCF Margin % is ranked worse than 65.5% of 826
companies
in the Medical Devices & Instruments industry
Industry Median: -7.29
vs NPCE: -30.38
NeuroPace FCF Margin % Historical Data
The historical data trend for NeuroPace's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NeuroPace's FCF Margin %
For the Medical Devices subindustry, NeuroPace's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuroPace's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NeuroPace's FCF Margin % distribution charts can be found below:
* The bar in red indicates where NeuroPace's FCF Margin % falls into.
NeuroPace FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
NeuroPace's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuroPace FCF Margin % Related Terms
Thank you for viewing the detailed overview of NeuroPace's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NPCE has been successfully added to your 